132 related articles for article (PubMed ID: 24929648)
1. The effect of image guidance on dose distributions in breast boost radiotherapy.
Donovan EM; Brooks C; Mitchell RA; Mukesh M; Coles CE; Evans PM; Harris EJ;
Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):671-6. PubMed ID: 24929648
[TBL] [Abstract][Full Text] [Related]
2. Dosimetric consequences of the shift towards computed tomography guided target definition and planning for breast conserving radiotherapy.
van der Laan HP; Dolsma WV; Maduro JH; Korevaar EW; Langendijk JA
Radiat Oncol; 2008 Jan; 3():6. PubMed ID: 18237427
[TBL] [Abstract][Full Text] [Related]
3. Planning with intensity-modulated radiotherapy and tomotherapy to modulate dose across breast to reflect recurrence risk (IMPORT High trial).
Donovan EM; Ciurlionis L; Fairfoul J; James H; Mayles H; Manktelow S; Raj S; Tsang Y; Tywman N; Yarnold J; Coles C
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1064-72. PubMed ID: 20605349
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric comparison of intensity-modulated radiotherapy plans, with or without anterior myocardial territory and left ventricle as organs at risk, in early-stage left-sided breast cancer patients.
Tan W; Wang X; Qiu D; Liu D; Jia S; Zeng F; Chen Z; Li B; Xu J; Wei L; Hu D
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1544-51. PubMed ID: 21470785
[TBL] [Abstract][Full Text] [Related]
5. A dosimetry study precisely outlining the heart substructure of left breast cancer patients using intensity-modulated radiation therapy.
Fan LL; Luo YK; Xu JH; He L; Wang J; Du XB
J Appl Clin Med Phys; 2014 Sep; 15(5):4624. PubMed ID: 25207559
[TBL] [Abstract][Full Text] [Related]
6. Cardiac Dose Control and Optimization Strategy for Left Breast Cancer Radiotherapy With Non-Uniform VMAT Technology.
Qiu J; Zhang S; Lv B; Zheng X
Technol Cancer Res Treat; 2021; 20():15330338211053752. PubMed ID: 34806481
[No Abstract] [Full Text] [Related]
7. Multisegmented tangential breast fields: a rational way to treat breast cancer.
Gulybán A; Kovács P; Sebestyén Z; Farkas R; Csere T; Karácsonyi G; Dérczy K; Hideghéty K; Esik O
Strahlenther Onkol; 2008 May; 184(5):262-9. PubMed ID: 18427757
[TBL] [Abstract][Full Text] [Related]
8. Hypofractionated whole-breast radiation therapy: does breast size matter?
Hannan R; Thompson RF; Chen Y; Bernstein K; Kabarriti R; Skinner W; Chen CC; Landau E; Miller E; Spierer M; Hong L; Kalnicki S
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):894-901. PubMed ID: 22543209
[TBL] [Abstract][Full Text] [Related]
9. Radiation during deep inspiration allows loco-regional treatment of left breast and axillary-, supraclavicular- and internal mammary lymph nodes without compromising target coverage or dose restrictions to organs at risk.
Hjelstuen MH; Mjaaland I; Vikström J; Dybvik KI
Acta Oncol; 2012 Mar; 51(3):333-44. PubMed ID: 22171587
[TBL] [Abstract][Full Text] [Related]
10. An Analysis of Plan Robustness for Esophageal Tumors: Comparing Volumetric Modulated Arc Therapy Plans and Spot Scanning Proton Planning.
Warren S; Partridge M; Bolsi A; Lomax AJ; Hurt C; Crosby T; Hawkins MA
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):199-207. PubMed ID: 27084641
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of OAR dose sparing and plan robustness of beam-specific PTV in lung cancer IMRT treatment.
Chang Y; Xiao F; Quan H; Yang Z
Radiat Oncol; 2020 Oct; 15(1):241. PubMed ID: 33069253
[TBL] [Abstract][Full Text] [Related]
12. Treatment planning strategy for whole-brain radiotherapy with hippocampal sparing and simultaneous integrated boost for multiple brain metastases using intensity-modulated arc therapy.
Pokhrel D; Sood S; McClinton C; Shen X; Lominska C; Saleh H; Badkul R; Jiang H; Mitchell M; Wang F
Med Dosim; 2016 Winter; 41(4):315-322. PubMed ID: 27692518
[TBL] [Abstract][Full Text] [Related]
13. [Dosimetric evaluation of intensity-modulated tangential beam versus conventional tangential irradiation for breast cancer].
Huang XB; Jiang GL; Chen JY; Chen LF; Hu WG
Ai Zheng; 2006 Jul; 25(7):855-60. PubMed ID: 16831277
[TBL] [Abstract][Full Text] [Related]
14. A topology-based method to mitigate the dosimetric uncertainty caused by the positional variation of the boost volume in breast conservative radiotherapy.
Lee PY; Lin CY; Chen SW; Chien CR; Chu CN; Hsu HT; Liang JA; Lin YJ; Shiau AC
Radiat Oncol; 2017 Mar; 12(1):55. PubMed ID: 28320428
[TBL] [Abstract][Full Text] [Related]
15. Multicatheter interstitial brachytherapy versus intensity modulated external beam therapy for accelerated partial breast irradiation: A comparative treatment planning study with respect to dosimetry of organs at risk.
Major T; Stelczer G; Pesznyák C; Mészáros N; Polgár C
Radiother Oncol; 2017 Jan; 122(1):17-23. PubMed ID: 27544819
[TBL] [Abstract][Full Text] [Related]
16. Impact of intensity-modulated radiation therapy as a boost treatment on the lung-dose distributions for non-small-cell lung cancer.
Choi Y; Kim JK; Lee HS; Hur WJ; Chai GY; Kang KM
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):683-9. PubMed ID: 15927412
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric Evaluation of Different Intensity-Modulated Radiotherapy Techniques for Breast Cancer After Conservative Surgery.
Zhang F; Wang Y; Xu W; Jiang H; Liu Q; Gao J; Yao B; Hou J; He H
Technol Cancer Res Treat; 2015 Oct; 14(5):515-23. PubMed ID: 25311257
[TBL] [Abstract][Full Text] [Related]
18. Cardiac-Sparing Whole Lung Intensity Modulated Radiation Therapy in Children With Wilms Tumor: Final Report on Technique and Abdominal Field Matching to Maximize Normal Tissue Protection.
Kalapurakal JA; Lee B; Bautista J; Rigsby C; Helenowski I; Gopalakrishnan M
Pract Radiat Oncol; 2019 Jan; 9(1):e62-e73. PubMed ID: 30096378
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer.
Da Silva Mendes V; Nierer L; Li M; Corradini S; Reiner M; Kamp F; Niyazi M; Kurz C; Landry G; Belka C
Radiat Oncol; 2021 Jul; 16(1):133. PubMed ID: 34289868
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy.
Koeck J; Abo-Madyan Y; Lohr F; Stieler F; Kriz J; Mueller RP; Wenz F; Eich HT
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):268-76. PubMed ID: 22079733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
